The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Associations of a breast cancer polygenic risk score with tumor characteristics and survival.
 
Josephine Lopes Cardozo
No Relationships to Disclose
 
Irene L. Andrulis
No Relationships to Disclose
 
Devilee Peter
No Relationships to Disclose
 
Thilo Dörk
No Relationships to Disclose
 
Caroline Drukker
No Relationships to Disclose
 
Peter A. Fasching
Honoraria - Agendia; AstraZeneca; BionTech (Inst); Cepheid (Inst); Daiichi Sankyo; Eisai; Gilead Sciences; Hexal; Lilly; Merck Sharp & Dohme; Novartis; Pfizer; Pierre Fabre; Roche; Seagen
Consulting or Advisory Role - Agendia; AstraZeneca; Daiichi Sankyo; Eisai; Gilead Sciences; Hexal; Lilly; Merck Sharp & Dohme; Novartis; Pfizer; Pierre Fabre; Roche; Seagen
Research Funding - BioNTech (Inst); Cepheid (Inst); Novartis (Inst); Roche
 
Maartje J. Hooning
No Relationships to Disclose
 
Renske Keeman
No Relationships to Disclose
 
Heli Nevanlinna
No Relationships to Disclose
 
Emiel J. Rutgers
Honoraria - Guerbet
 
Laura van 't Veer
Employment - Agendia
Stock and Other Ownership Interests - Agendia
 
Per Hall
Stock and Other Ownership Interests - ICAD
Research Funding - Atossa Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - Pending patent on compositions and methods for prevention of breast cancer with an option to license to Atossa Therapeutics. Licensed the algorithm for risk prediction based on analyses of mammographic features to iCAD.
 
Stig Egil Bojesen
No Relationships to Disclose
 
Easton Douglas
Patents, Royalties, Other Intellectual Property - Royalties from Boadicea risk prediction tool (Inst)
 
Diana Eccles
Honoraria - AstraZeneca Canada; Pierre Fabre
Consulting or Advisory Role - AstraZeneca Canada
Travel, Accommodations, Expenses - Pierre Fabre
 
Paul Pharoah
Patents, Royalties, Other Intellectual Property - I receive a share of the fees for a patent held by the University of Cambridge of a seven SNP polygenic risk assay.; The PREDICT breast cancer prognostic model is licensed to OncoAssist by the University of Cambridge. I receive a share of the fees.
 
Marjanka Schmidt
No Relationships to Disclose